Christopher Hite Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 12 hours ago
Christopher Hite has an estimated net worth of at least $46.1 million*, as of Sept. 2, 2026. They own 393,601 shares of RPRX stock. They have sold 380,000 shares of RPRX stock since 2021, for an estimated $21.5 million.
Christopher Hite $RPRX SEC Form 4 Insider Trading
Christopher Hite has filed a total of 7 insider trades in $RPRX since 2021. Their most recent trade was a sale of 100,000 shares, made on Aug 18, 2026. Their largest trade was a sale of 117,592 shares, made on Jun 23, 2026. We estimate that they now own 393,601 shares of $RPRX, worth an estimated $24.6 million.
Insider Trading at $RPRX
There have been a total of 233 insider trades reported at $RPRX since 2021, with 632,500 shares purchased and 14.5 million shares sold. The most active insider traders in $RPRX stock have been George W. Lloyd, Terrance P. Coyne, and George W. Lloyd. The most recent trade was a sale of 100,000 shares reported by Christopher Hite (EVP & Chairman, Partnering), made on Aug 18, 2026.
History of Insider Stock Trades by Christopher Hite
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RPRX
|
Sale | 100,000 | Aug 18, 2026 | Aug. 19, 2026, 4:20 p.m. |
RPRX
|
Sale | 97,446 | Jun 30, 2026 | July 2, 2026, 4:08 p.m. |
RPRX
|
Sale | 2,554 | Jun 30, 2026 | July 2, 2026, 4:08 p.m. |
RPRX
|
Sale | 29,400 | Jun 30, 2026 | July 2, 2026, 4:08 p.m. |
RPRX
|
Sale | 600 | Jun 30, 2026 | July 2, 2026, 4:08 p.m. |
RPRX
|
Sale | 32,408 | Jun 23, 2026 | June 25, 2026, 5:11 p.m. |
RPRX
|
Sale | 117,592 | Jun 23, 2026 | June 25, 2026, 5:11 p.m. |
$RPRX Executives and Stock Owners with Insider Trades
-
George W. Lloyd, EVP, Investments & GC
-
Terrance P. Coyne, EVP & CFO
-
George W. Lloyd, EVP, Investments & CLO
-
Marshall Urist, EVP, Research & Investments
-
James F. Reddoch, EVP, Research & Investments
-
Christopher Hite, EVP & Chairman, Partnering
-
Pablo G. Legorreta, CEO, Chairman of the Board
-
James F. Reddoch, EVP & Chief Scientific Officer
-
Marshall Urist, EVP & Co-Head of R&I
-
Marshall Urist, EVP & Co-Head Research & Inv.
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.